# Randomised Trial of Structured Treatment Interruption of HAART in HIV-Infected Adults in Abidjan (ANRS 1269 TRIVACAN)

> **NCT00158405** · PHASE3 · COMPLETED · sponsor: **French National Agency for Research on AIDS and Viral Hepatitis** · enrollment: 840 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **PROCEDURE:** Structured Treatment Interruption
- **DRUG:** Zidovudine (ZDV)
- **DRUG:** Lamivudine (3TC)
- **DRUG:** Efavirenz (EFV)
- **DRUG:** Ritonavir (NRV)
- **DRUG:** Indinavir (IDV)

## Key facts

- **NCT ID:** NCT00158405
- **Lead sponsor:** French National Agency for Research on AIDS and Viral Hepatitis
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-12
- **Primary completion:** —
- **Final completion:** 2006-12
- **Target enrollment:** 840 (ACTUAL)
- **Last updated:** 2008-12-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00158405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00158405, "Randomised Trial of Structured Treatment Interruption of HAART in HIV-Infected Adults in Abidjan (ANRS 1269 TRIVACAN)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00158405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*